These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 9767637)

  • 1. A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds.
    van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; Ijzerman AP
    J Med Chem; 1998 Oct; 41(21):3994-4000. PubMed ID: 9767637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel class of adenosine A3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives.
    van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; IJzerman AP
    J Med Chem; 1998 Oct; 41(21):3987-93. PubMed ID: 9767636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoquinoline and quinazoline urea analogues as antagonists for the human adenosine A(3) receptor.
    van Muijlwijk-Koezen JE; Timmerman H; van der Goot H; Menge WM; Frijtag Von Drabbe Künzel J; de Groote M; IJzerman AP
    J Med Chem; 2000 Jun; 43(11):2227-38. PubMed ID: 10841801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor.
    van Tilburg EW; von Frijtag Drabbe Künzel J; de Groote M; Vollinga RC; Lorenzen A; IJzerman AP
    J Med Chem; 1999 Apr; 42(8):1393-400. PubMed ID: 10212125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
    van Muijlwijk-Koezen JE; Timmerman H; Vollinga RC; Frijtag von Drabbe Künzel J; de Groote M; Visser S; IJzerman AP
    J Med Chem; 2001 Mar; 44(5):749-62. PubMed ID: 11262085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
    Müller CE; Geis U; Grahner B; Lanzner W; Eger K
    J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a new scaffold to develop potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
    Colotta V; Lenzi O; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Traini C; Pedata F; Morizzo E; Moro S
    J Med Chem; 2009 Apr; 52(8):2407-19. PubMed ID: 19301821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
    Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.
    Fernández F; Caamaño O; Isabel Nieto M; López C; García-Mera X; Stefanachi A; Nicolotti O; Isabel Loza M; Brea J; Esteve C; Segarra V; Vidal B; Carotti A
    Bioorg Med Chem; 2009 May; 17(10):3618-29. PubMed ID: 19398343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Romagnoli R; Preti D; Bovero A; Pineda de Las Infantas MJ; Moorman A; Varani K; Borea PA
    J Med Chem; 2004 Oct; 47(22):5535-40. PubMed ID: 15481989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
    Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE
    Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and 3D QSAR of new pyrazolo[3,4-b]pyridines: potent and selective inhibitors of A1 adenosine receptors.
    Manetti F; Schenone S; Bondavalli F; Brullo C; Bruno O; Ranise A; Mosti L; Menozzi G; Fossa P; Trincavelli ML; Martini C; Martinelli A; Tintori C; Botta M
    J Med Chem; 2005 Nov; 48(23):7172-85. PubMed ID: 16279775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological studies of a new series of 5-heteroarylcarbamoylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as human A3 adenosine receptor antagonists. Influence of the heteroaryl substituent on binding affinity and molecular modeling investigations.
    Pastorin G; Da Ros T; Bolcato C; Montopoli C; Moro S; Cacciari B; Baraldi PG; Varani K; Borea PA; Spalluto G
    J Med Chem; 2006 Mar; 49(5):1720-9. PubMed ID: 16509587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
    J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Bergonzoni M; Dionisotti S; Ongini E; Varani K; Borea PA
    J Med Chem; 1998 Jun; 41(12):2126-33. PubMed ID: 9622554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability.
    Yan L; Müller CE
    J Med Chem; 2004 Feb; 47(4):1031-43. PubMed ID: 14761205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
    Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Westerhout J; Spangenberg T; Brussee J; Ijzerman AP
    J Med Chem; 2007 Feb; 50(4):828-34. PubMed ID: 17300165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.